文献速递神经肿瘤

胶质瘤分级与转化能力的关键速率:模型模拟与临床病例

Key rates for the grades and transformation ability of glioma: model simulations and clinical cases.
PubMed 文献 · J Neurooncol · 2017-04-27

该研究通过模型模拟胶质瘤2-4级在诊断和死亡时的病理与影像特征,并对临床病例进行回顾性分析。模拟发现部分2级和3级胶质瘤缺乏进展为更高级别的能力,而3级胶质瘤可在数周内演变为胶质母细胞瘤(GBM)。所有13例同级别复发的胶质瘤均携带IDH1-R132H或ATRX突变;5例3级肿瘤均为1p/19q共缺失、IDH1-R132H突变且ATRX野生型;7例2级胶质瘤中3例同时具有IDH1-R132H和ATRX突变。

要点

  • 部分2级和3级胶质瘤缺乏进展为更高级别的能力。
  • 3级胶质瘤可在数周内演变为GBM。
  • 同级别复发的胶质瘤均携带IDH1-R132H或ATRX突变。

核心结论

  • 结果支持恒定速率的弥散、增殖和血管生成决定自然演变或无法进展为更高级别的假说,而改变肿瘤浸润、增殖或新生血管化能力的分子事件累积可使胶质瘤在同一级别内更具侵袭性或提升级别。

研究设计与样本

  • 基于模型预测的临床病例回顾性综述,模拟2-4级胶质瘤在诊断和死亡时的病理与影像特征。

主要发现

  • 模拟发现两种不寻常的胶质瘤进展模式:部分2级和3级胶质瘤缺乏进展为更高级别的能力;3级胶质瘤可在数周内演变为GBM。
  • 所有13例同级别复发的胶质瘤均携带IDH1-R132H或ATRX突变。
  • 5例3级肿瘤均为1p/19q共缺失、IDH1-R132H突变且ATRX野生型。
  • 7例2级胶质瘤中3例同时具有IDH1-R132H和ATRX突变。
  • 模拟再现了继发性GBM的良好预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tumor progression to higher grade is a fundamental property of cancer. The malignant advancement of the pathological features may either develop during the later stages of cancer growth (natural evolution) or it may necessitate new mutations or molecular events that alter the rates of growth, dispersion, or neovascularization (transformation). Here, we model the pathological and radiological features of grades 2-4 gliomas at the times of diagnosis and death and study grade development and the progression to higher grades. We perform a retrospective review of clinical cases based on model predictions. Simulations uncover two unusual patterns of glioma progression, which are supported by clinical cases: (1) some grades 2 and 3 gliomas lack the ability of progression to higher grades, and (2) grade 3 glioma may evolve to GBM in a few weeks. All 13 gliomas that recurred at the same grade carry either the IDH1-R132H or the ATRX mutation. All (five of five) grade 3 tumors are 1p/19q co-deleted, IDH1-R132H mutated and ATRX wt. Furthermore, three of seven grade 2 gliomas are both IDH1-R132H mutated and ATRX mutated. Simulations replicate the good prognosis of secondary GBM. The results support the hypothesis that constant rates of dispersion, proliferation, and angiogenesis prescribe either a natural evolution or the inability to progress to higher grades. Furthermore, the accrual of molecular events that change a tumor's ability to infiltrate, proliferate or neovascularize may transform the glioma either into a more aggressive tumor at the same grade or elevate its grade.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Scribner E, Hackney JR, Machemehl HC, et al. Key rates for the grades and transformation ability of glioma: model simulations and clinical cases. J Neurooncol. 2017. PMID: 28451993. doi:10.1007/s11060-017-2444-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。